Profile | GDS4284 / 1560654_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 217.615 | 51 |
GSM687648 | Patient 402 control | 61.9505 | 27 |
GSM687653 | Patient 403 control | 191.196 | 49 |
GSM687658 | Patient 404 control | 93.8275 | 33 |
GSM687663 | Patient 411 control | 138.043 | 39 |
GSM687668 | Patient 422 control | 38.9448 | 20 |
GSM687673 | Patient 424 control | 9.55015 | 4 |
GSM687678 | Patient 425 control | 93.8675 | 32 |
GSM687683 | Patient 427 control | 143.083 | 39 |
GSM687688 | Patient 428 control | 188.719 | 47 |
GSM687695 | Patient 441 control | 41.9947 | 13 |
GSM687699 | Patient 443 control | 152.922 | 39 |
GSM687704 | Patient 444 control | 141.948 | 41 |
GSM687707 | Patient 448 control | 228.288 | 48 |
GSM687712 | Patient 449 control | 74.2815 | 29 |
GSM687719 | Patient 450 control | 144.819 | 38 |
GSM687724 | Patient 451 control | 224.968 | 49 |
GSM687728 | Patient 452 control | 86.7711 | 29 |
GSM687646 | Patient 401 treated 24h | 150.6 | 42 |
GSM687649 | Patient 402 treated 24h | 62.483 | 28 |
GSM687665 | Patient 411 treated 24h | 9.71632 | 4 |
GSM687651 | Patient 402 treated 4 weeks | 79.9745 | 29 |
GSM687667 | Patient 411 treated 4 weeks | 151.641 | 42 |
GSM687670 | Patient 422 treated 24h | 107.479 | 35 |
GSM687671 | Patient 422 treated 4 weeks | 85.4946 | 32 |
GSM687654 | Patient 403 treated 24h | 169.36 | 47 |
GSM687675 | Patient 424 treated 24h | 53.0216 | 22 |
GSM687685 | Patient 427 treated 24h | 134.009 | 40 |
GSM687656 | Patient 403 treated 4 weeks | 47.1671 | 24 |
GSM687677 | Patient 424 treated 4 weeks | 76.438 | 30 |
GSM687687 | Patient 427 treated 4 weeks | 108.571 | 38 |
GSM687692 | Patient 428 treated 4h | 172.329 | 45 |
GSM687716 | Patient 449 treated 4h | 125.423 | 39 |
GSM687722 | Patient 450 treated 4h | 153.048 | 39 |
GSM687680 | Patient 425 treated 24h | 83.1168 | 31 |
GSM687690 | Patient 428 treated 24h | 150.416 | 44 |
GSM687700 | Patient 443 treated 24h | 125.989 | 31 |
GSM687705 | Patient 444 treated 24h | 110.581 | 38 |
GSM687714 | Patient 449 treated 24h | 94.2435 | 35 |
GSM687721 | Patient 450 treated 24h | 16.4001 | 7 |
GSM687682 | Patient 425 treated 4 weeks | 57.5137 | 25 |
GSM687694 | Patient 428 treated 4 weeks | 139.638 | 43 |
GSM687702 | Patient 443 treated 4 weeks | 166.541 | 42 |
GSM687718 | Patient 449 treated 4 weeks | 101.581 | 34 |
GSM687723 | Patient 450 treated 4 weeks | 109.954 | 35 |
GSM687661 | Patient 404 treated 4h | 176.742 | 45 |
GSM687710 | Patient 448 treated 4h | 88.8573 | 32 |
GSM687726 | Patient 451 treated 4h | 18.6331 | 9 |
GSM687730 | Patient 452 treated 4h | 77.1037 | 18 |
GSM687660 | Patient 404 treated 24h | 137.168 | 36 |
GSM687697 | Patient 441 treated 24h | 25.7081 | 10 |
GSM687709 | Patient 448 treated 24h | 58.9635 | 24 |
GSM687725 | Patient 451 treated 24h | 279.385 | 52 |
GSM687729 | Patient 452 treated 24h | 236.828 | 46 |
GSM687727 | Patient 451 treated 4 weeks | 169.223 | 41 |
GSM687731 | Patient 452 treated 4 weeks | 125.319 | 36 |